RECRUITING

TELESCOPE- TELEhealth Shared Decision-making COaching

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Hypothesis 1a: The investigators anticipate that navigator decision coaching, compared to enhanced usual care (EUC) will result in higher quality SDM for lung cancer screening (LCS )(primary outcome), greater knowledge of lung cancer screening benefits and harms, and lower decisional conflict. Hypothesis 1b: Compared to enhanced usual care (EUC), we expect that TELESCOPE will result in more screening discussions, increased initial for lung cancer screening (LCS) with low-dose CT scan (LDCT) uptake among interested participants, increased adherence to repeat LCS and diagnostic testing, and increased smoking cessation referrals for current smokers. Hypothesis 2: The investigators expect that a "booster" coaching session will increase adherence to repeat lung cancer screening (LCS).

Official Title

TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary carE (TELESCOPE)

Quick Facts

Study Start:2023-02-14
Study Completion:2027-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05491213

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Be 50 to 77 years of age
  2. * Be a current or former smoker having quit within the past 15 years
  3. * Have at least a 20 pack-year smoking history
  4. * Be scheduled for a non-acute care visit at one of the study sites. Interviews (N=50)
  5. * A practicing primary care clinician or a clinic director (n=20), nursing director, or clinic practice administrator (n=20) at one of the participating sites or a TELESCOPE study patient navigator (n=7) and nurse navigator (n = 3)
  6. * Age 18 or older
  7. * Fluent in English Online surveys (N=130)
  8. * A practicing primary care provider at one of the participating sites or a TELESCOPE study navigator
  9. * Age 18 or older
  10. * Fluent in English
  1. * Do not speak English
  2. * Have a history lung cancer
  3. * Were screened for lung cancer within the past 12 months
  4. * Have health conditions that make them poor candidates for curative treatment as determined by the primary care provider
  5. * Are unable to provide informed consent Interviews (N=50)
  6. * Are unable to provide informed consent Online surveys (N=130)
  7. * Are unable to provide informed consent
  8. * Women who are pregnant. English proficiency is required for the completion of surveys, and the intervention will be conducted in English.

Contacts and Locations

Study Contact

Julie E Chapman-Greene, PhD, MPH
CONTACT
732-865-3375
chapmaje@cinj.rutgers.edu
Rebecca Ayala
CONTACT
732-258-6982
raa191@cinj.rutgers.edu

Principal Investigator

Anita Y Kinney, PhD, RN
PRINCIPAL_INVESTIGATOR
Rutgers Cancer Institute of New Jersey

Study Locations (Sites)

Rutgers, Cancer Institute of New Jersey
New Brunswick, New Jersey, 08901
United States
The University of Texas MD Anderson Cancer Center
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: Rutgers, The State University of New Jersey

  • Anita Y Kinney, PhD, RN, PRINCIPAL_INVESTIGATOR, Rutgers Cancer Institute of New Jersey

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-02-14
Study Completion Date2027-12-31

Study Record Updates

Study Start Date2023-02-14
Study Completion Date2027-12-31

Terms related to this study

Keywords Provided by Researchers

  • Lung cancer screening
  • Shared decision making

Additional Relevant MeSH Terms

  • Lung Neoplasms